Propylthiouracil is generally considered safer than other antithyroid medications, such as methimazole, during the first trimester of pregnancy. This is due to the lower risk of congenital malformations. However, long-term use of PTU is associated with risks such as liver toxicity, so careful monitoring and potential switching to other medications later in pregnancy may be necessary.
